RecruitingNCT05950750

Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study


Sponsor

Turkish Hematology Association

Enrollment

960 participants

Start Date

Dec 21, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

21 hematology centers in Turkey will participate in this noninterventional observational study. The recruitment target is 960 cases. Patients will be followed-up at least 1 year or to the end of the study according to the physicians' discretion, or withdrawal of consent. Recruitment period will be 36 months. Data will be collected via electronic case report form. Since the study cohort does not include only newly diagnosed patients, all aTTP patients will be included to the study, previous treatments and diagnosis information data could also be collected from hospital records. Patients recruitment duration: 3 years (36 months) Patients follow-up duration: 1 year (12 months)


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Diagnosed as aTTP after 01.01.2015
  • Patients with ADAMS13\<10%
  • Thrombocytopenia (\<100.000)
  • Coombs (-)
  • Microangiopathic hemolytic amenia
  • years and older

Exclusion Criteria1

  • \- Patient who does not sign informed consent form

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Baskent Universtiy Faculty of Medicine

Ankara, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05950750


Related Trials